Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. David P. PerryPresident and CEO361,3060.82%2014-03-04
Mr. Paul L. BernsPresident and CEO254,7600.58%2015-08-13
Mr. Geoffrey M. ParkerExecutive Vice President & CFO94,8400.22%2015-03-23
Vincent IppolitoEVP & Chief Commercial Officer70,6030.16%2015-03-03
Paul H. KlingensteinDirector58,0010.13%2010-11-30
Sanjay ChandaSVP, Drug Development29,087less than 0.1%2015-03-04
Dr. Lee T. Zane, M.D.,M.A.S.SVP and Chief Medical Officer28,156less than 0.1%2015-06-15
Ryan T. SullivanSr. VP and General Counsel27,740less than 0.1%2015-04-29
Dr. Kirk R. Maples, PhDSVP, Program Management7,220less than 0.1%2015-06-01
Ms. Carmen R. RodriguezSnr VP Reg Afrs & Qual. Assur.7,020less than 0.1%2015-05-12

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
BERNS PAUL LPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-08-13Sell20,000254,760$138.692773.8-4.14254,760 (Direct)
Zane LeeSVP and Chief Medical Officer2015-06-15Sell12,00028,156$69.05828.692.5428,156 (Direct)
Maples Kirk RSVP, Program Management2015-06-01Sell6007,220$70.3142.289.097,220 (Direct)
Plattner Jacob jSenior VP, Research2015-05-15Sell8,92022,860$63.73568.5108.615,020 (Direct)
17,840 (See Footnote)
Rodriguez Carmen RSnr VP Reg Afrs & Qual. Assur.2015-05-14Sell61,9427,020$62.733885.6111.947,020 (Direct)
Maples Kirk RSVP, Program Management2015-05-12Sell6,0607,820$61.07370.1117.77,820 (Direct)
Maples Kirk RSVP, Program Management2015-05-01Sell6007,820$53.9532.4146.437,820 (Direct)
Sullivan Ryan TSr. VP and General Counsel2015-04-29Sell3,12527,740$53.61167.5147.9927,740 (Direct)
BERNS PAUL LPresident and CEO2015-04-27Sell50,000253,760$63.643182108.91253,760 (Direct)
Plattner Jacob jSenior VP, Research2015-04-15Sell8,92031,780$62.81560.3111.675,020 (Direct)
26,760 (See Footnote)
Maples Kirk RSVP, Program Management2015-04-01Sell6008,420$57.0234.2133.168,420 (Direct)
Parker Geoffrey M.Executive Vice President & CFO2015-03-23Buy3,000104,840$52.43157.3153.5894,840 (Direct)
10,000 (See Footnote)
BERNS PAUL LPresident and CEO2015-03-19Sell37,500308,760$56.072102.6137.11308,760 (Direct)
Plattner Jacob jSenior VP, Research2015-03-16Sell8,92040,700$55.6496139.125,020 (Direct)
35,680 (See Footnote)
Zane LeeSVP and Chief Medical Officer2015-03-16Sell12,00028,156$56.44677.3135.5628,156 (Direct)
Chanda SanjaySVP, Drug Development2015-03-04Sell5,00029,087$45225195.4429,087 (Direct)
IPPOLITO VINCENT PEVP & Chief Commercial Officer2015-03-03Sell9,00070,603$43.88394.9202.9970,603 (Direct)
Plattner Jacob jSenior VP, Research2015-03-02Sell6,87549,620$44.02302.6202.025,020 (Direct)
44,600 (See Footnote)
Maples Kirk RSVP, Program Management2015-03-02Sell6009,020$43.9526.4202.59,020 (Direct)
Plattner Jacob jSenior VP, Research2015-02-02Sell6,87551,475$37.35256.8255.96
51,475 (See Footnote)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK